Plantronics, Inc.
POLY · NYSE
7/2/2022 | 4/2/2022 | 1/1/2022 | 10/2/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.34 | -0.08 | 0.25 | -0.01 |
| FCF Yield | -0.59% | -0.99% | -0.62% | -0.71% |
| EV / EBITDA | 165.95 | 173.32 | 81.23 | 51.96 |
| Quality | ||||
| ROIC | -1.04% | -0.97% | -0.15% | -10.05% |
| Gross Margin | 40.44% | 39.64% | 40.09% | 42.88% |
| Cash Conversion Ratio | 0.09 | 0.25 | -0.01 | -0.01 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.24% | -0.31% | -0.50% | -1.23% |
| Free Cash Flow Growth | 39.65% | -116.50% | 0.65% | -49.74% |
| Safety | ||||
| Net Debt / EBITDA | 73.17 | 76.57 | 41.85 | 28.36 |
| Interest Coverage | -1.12 | -1.19 | -0.30 | 0.64 |
| Efficiency | ||||
| Inventory Turnover | 1.01 | 1.09 | 1.13 | 1.15 |
| Cash Conversion Cycle | 85.70 | 82.53 | 81.25 | 73.43 |